Detalhe da pesquisa
1.
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.
J Clin Invest
; 131(10)2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830945
2.
ST2 as checkpoint target for colorectal cancer immunotherapy.
JCI Insight
; 5(9)2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376804
3.
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.
Nat Commun
; 9(1): 4394, 2018 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30349055
4.
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.
Nat Commun
; 9(1): 4718, 2018 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413718